C21 Investments Inc (CXXIF)
0.243
0.00 (0.00%)
USD |
OTCM |
Sep 20, 09:43
C21 Investments EPS Diluted (Quarterly): -0.01 for June 30, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.01 |
| January 31, 2024 | -0.02 |
| October 31, 2023 | -0.0031 |
| July 31, 2023 | -0.0035 |
| April 30, 2023 | -0.0039 |
| January 31, 2023 | -0.02 |
| October 31, 2022 | 0.002 |
| July 31, 2022 | 0.02 |
| April 30, 2022 | 0.00 |
| January 31, 2022 | -0.02 |
| October 31, 2021 | 0.02 |
| July 31, 2021 | 0.03 |
| April 30, 2021 | 0.04 |
| January 31, 2021 | -0.0749 |
| October 31, 2020 | 0.01 |
| July 31, 2020 | -0.0004 |
| April 30, 2020 | -0.02 |
| January 31, 2020 | -0.28 |
| October 31, 2019 | -0.06 |
| July 31, 2019 | -0.04 |
| April 30, 2019 | -0.05 |
| January 31, 2019 | -0.196 |
| October 31, 2018 | -0.15 |
| July 31, 2018 | -0.23 |
| April 30, 2018 | -0.17 |
| Date | Value |
|---|---|
| January 31, 2018 | -0.0243 |
| October 31, 2017 | -0.0546 |
| July 31, 2017 | -0.008 |
| April 30, 2017 | -0.0073 |
| January 31, 2017 | -0.008 |
| October 31, 2016 | -0.0075 |
| July 31, 2016 | -0.0077 |
| April 30, 2016 | -0.008 |
| January 31, 2016 | -0.0073 |
| October 31, 2015 | -0.0062 |
| July 31, 2015 | -0.0155 |
| April 30, 2015 | -0.0079 |
| January 31, 2015 | -0.0423 |
| October 31, 2014 | -0.0095 |
| July 31, 2014 | -0.0151 |
| April 30, 2014 | -0.0123 |
| January 31, 2014 | -0.0838 |
| October 31, 2013 | -0.044 |
| July 31, 2013 | -0.2911 |
| April 30, 2013 | -0.0311 |
| January 31, 2013 | 0.0027 |
| October 31, 2012 | -0.044 |
| July 31, 2012 | -0.5989 |
| April 30, 2012 | 0.0238 |
| January 31, 2012 | -0.0998 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.28
Minimum
Jan 2020
0.04
Maximum
Apr 2021
-0.0207
Average
-0.0035
Median
Jul 2023
EPS Diluted (Quarterly) Benchmarks
| Acasti Pharma Inc | -0.24 |
| Aurinia Pharmaceuticals Inc | 0.01 |
| Edesa Biotech Inc | -0.52 |
| Lexaria Bioscience Corp | -0.13 |
| Xenon Pharmaceuticals Inc | -0.75 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.412M |
| Revenue (Quarterly) | 6.596M |
| Total Expenses (Quarterly) | 7.436M |
| Enterprise Value | 28.72M |
| Gross Profit Margin (Quarterly) | 30.79% |
| Profit Margin (Quarterly) | -21.41% |
| Earnings Yield | -15.06% |
| Operating Earnings Yield | 0.26% |
| Normalized Earnings Yield | -12.33 |